Retrospective studies on drug utilization patterns of asthmatics in a Government hospital in Kedah, Malaysia

Authors

  • Sam Aseer Thamby Faculty of Pharmacy, AIMST University, 08100 Bedong
  • Puah Juling Faculty of Pharmacy, AIMST University, 08100 Bedong
  • Bernice Ting Wan Xin Faculty of Pharmacy, AIMST University, 08100 Bedong
  • Ngo Chooi Jing Faculty of Pharmacy, AIMST University, 08100 Bedong

DOI:

https://doi.org/10.3329/icpj.v1i11.12060

Keywords:

Salbutamol, Combivent, Symbicort, Turbuhaler, Nebulizer, Handihaler

Abstract

Retrospective DUE is the reviewing of drug therapy after the patient has received the medication. Asthma is a common chronic disease in Malaysia. A National Health and Morbidity Survey in 1996 indicated that asthma prevalence in Malaysia was 4.2%. Statistics on the causes of death have noted asthma as one of the 10 principal causes of death (7.3%) in Malaysia. The purpose of the study was to compare drug utilization patterns amongst the asthmatics from the past two years (since 2009) in Kedah state. Asthmatics admitted to the hospital in the preceding two years were analyzed by their patient charts. This study focused on both smoker and non smoker asthmatics. It was observed that salbutamol was most commonly prescribed, followed by montelukast and prednisolone. In the combination therapy, the most commonly prescribed was Symbicort, followed by seretide and combivent. Corticosteroids constituted the most prevalent class, followed by beta-2 agonists, leukotriene modifiers and methylxanthines. The study presented the most recent scenario on drug utilization pattern of asthmatics in Kedah state.

DOI: http://dx.doi.org/10.3329/icpj.v1i11.12060

International Current Pharmaceutical Journal 2012, 1(11): 353-360

 

Downloads

Download data is not yet available.
Abstract
911
PDF
1405

Downloads

Published

2012-10-03

How to Cite

Thamby, S. A., Juling, P., Xin, B. T. W., & Jing, N. C. (2012). Retrospective studies on drug utilization patterns of asthmatics in a Government hospital in Kedah, Malaysia. International Current Pharmaceutical Journal, 1(11), 353–360. https://doi.org/10.3329/icpj.v1i11.12060

Issue

Vol. 1 No. 11 (2012)

Section

Original Articles

License

Authors who publish with this journal agree to the following terms:

  1. The journal holds copyright and publishes the work under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).